Ella Lawson: Could Erythritol Harm the Brain’s Blood Vessels?
Ella Lawson, Manager of Logistics Operations at Stryker, shared a post on LinkedIn:
”A new lab study suggests that the sugar substitute Erythritol – commonly used in so-called ‘sugar-free’ or low-calorie foods – may harm the blood-brain barrier and the tiny blood vessels in the brain.
Researchers exposed human brain microvascular endothelial cells (the cells lining the brain’s smallest blood vessels) to amounts of erythritol similar to those found in a single sweetened beverage. They discovered the exposed cells produced significantly more reactive oxygen species (a sign of oxidative stress), generated less nitric oxide (a molecule that allows blood vessels to relax), produced more endothelin-1 (which constricts vessels), and showed reduced release of a key clot-dissolving enzyme. All of these changes are well-known contributors to impaired blood flow, vessel damage, and stroke risk.
While these findings are concerning, it’s important to keep in mind that the study was conducted in lab-grown cells and did not involve living humans. That means it shows a possible mechanism for harm, but does not prove that consuming erythritol at normal dietary levels will definitely cause brain vessel disease or stroke.
Researchers say more human studies are needed. In the meantime, people – especially those with risk factors for vascular or brain diseases—may want to limit the amount of erythritol they consume and consider naturally-derived alternatives like stevia or monk fruit, while focusing on whole-food approaches rather than relying on sugar substitutes.”

Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids